Japan has approved groundbreaking iPS stem cell treatments for heart failure and Parkinson’s disease, potentially shifting medicine toward organ repair.
Japan has approved groundbreaking iPS stem cell treatments for heart failure and Parkinson’s disease, potentially shifting medicine toward organ repair.